Trial Profile
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Projects #3
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Acronyms UdallP3
- 02 Jul 2019 Status changed from recruiting to completed.
- 18 Oct 2016 New trial record